首页> 外文期刊>Dermatology: international journal for clinical and investigative dermatology >Pityriasis rubra pilaris: Treatment with biologics - A new promising therapy?
【24h】

Pityriasis rubra pilaris: Treatment with biologics - A new promising therapy?

机译:糠疹糠疹(Pityriasis rubra pilaris):生物制剂治疗-一种新的有希望的治疗方法?

获取原文
获取原文并翻译 | 示例
           

摘要

Pityriasis rubra pilaris (PRP) includes a spectrum of rare chronic inflammatory disorders with papulosquamous eruptions of unknown cause. Different etiologies have been proposed such as vitamin A metabolism dysfunction, association with autoimmune disorders, infection or malignancies. However, PRP seems to be a polygenic skin disorder. Classical systemic treatment is empirical and includes retinoids and methotrexate; however, only few series on treatments exist. Recently there has been an increasing number of reports documenting that new biologicals and in particular TNF-α blockers are safe and effective.
机译:毛疹糠疹(PRP)包括一系列罕见的慢性炎症性疾病,病因不明的丘疹性皮疹。已经提出了不同的病因,例如维生素A代谢功能障碍,与自身免疫性疾病,感染或恶性肿瘤有关。但是,PRP似乎是一种多基因皮肤病。经典的全身治疗是经验性的,包括类维生素A和甲氨蝶呤。但是,关于治疗的系列很少。最近,越来越多的报告证明新的生物制剂,尤其是TNF-α阻断剂是安全有效的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号